title: Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.
authors.affiliation: Department of Ophthalmology, Erciyes University School of Medicine, Kayseri, Turkey. cagataykaraca@me.com
authors.forename: Cagatay
authors.initials: C
authors.lastname: Karaca
authors.forename: Ayse Ozturk
authors.initials: AO
authors.lastname: Oner
authors.forename: Ertugrul
authors.initials: E
authors.lastname: Mirza
authors.forename: Osman Ahmet
authors.initials: OA
authors.lastname: Polat
authors.forename: Mustafa
authors.initials: M
authors.lastname: Sahiner
mesh_terms: D020533:Angiogenesis Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068258:Bevacizumab; D003131:Combined Modality Therapy; D005865:Gestational Age; D006801:Humans; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D058449:Intravitreal Injections; D017075:Laser Coagulation; D008297:Male; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000601:surgery; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000601:surgery; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab